Bioxytran Inc (BIXT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2017 | 03-2017 | 12-2016 | 09-2016 | 06-2016 | |
| Sales | 40 | 7 | 58 | 101 | 56 |
| Cost of Goods | 19 | 14 | 23 | 38 | 19 |
| Gross Profit | 20 | -6 | 36 | 63 | 37 |
| Operating Expenses | 298 | 70 | -80 | 313 | 199 |
| Operating Income | -259 | -63 | 137 | -212 | -143 |
| Interest Expense | 2 | 2 | 2 | 2 | 2 |
| Other Income | 0 | 0 | 0 | 0 | -18 |
| Pre-tax Income | -260 | -65 | 135 | -214 | -163 |
| Net Income Continuous | -260 | -65 | 135 | -214 | -163 |
| Net Income | $-260 | $-65 | $135 | $-214 | $-163 |
| EPS Basic Total Ops | -0.01 | -0.03 | 0.01 | -0.01 | -0.01 |
| EPS Basic Continuous Ops | -0.01 | 0.00 | 0.01 | -0.01 | -0.01 |
| EPS Diluted Total Ops | -0.01 | -0.03 | 0.01 | -0.01 | -0.01 |
| EPS Diluted Continuous Ops | -0.01 | 0.00 | 0.01 | -0.01 | -0.01 |
| EBITDA(a) | $-254 | $-58 | $142 | $-207 | $-137 |